Investigators from the American Heart Association suggest that implantable cardioverter-defibrillator (ICD) therapy is not commonly used in survivors of in-hospital cardiac arrest despite the potential for this therapy to lower long-term mortality. ICD treatment was associated with a 24% lower mortality rate among participants, but was used in less than 30% of patients involved in the study.
Source: American Heart Journal, June 2015.
